Early detection of safety liabilities of new therapies is a critical biopharmaceutical challenge. Addressing this challenge could significantly advance drug discovery. Advanced human cell models, ...
Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding. The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience ...
External Quality Assessment (EQA) is a cornerstone in maintaining and improving the accuracy, reliability and comparability of clinical laboratory test results worldwide. By systematically comparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback